Plain-English translation of NCT07314268 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying tiny particles in the blood called extracellular vesicles to see if they can help doctors diagnose and track a rare heart condition caused by misfolded protein buildup. This study compares blood samples from people with the heart form of this disease, people with a nerve form of it, people who carry the gene but have no symptoms yet, and healthy people.
Currently, doctors struggle to catch this heart disease early, which often leads to delayed diagnosis and worse outcomes. This research aims to find new blood-based markers that could improve early detection and help doctors predict how the disease will progress in each person.
You likely qualify if…
You likely don't qualify if…
You will have blood drawn so researchers can isolate and study those tiny particles. If you have the heart form of the disease, you will also undergo cardiac tests such as heart ultrasounds (echocardiograms), heart MRI scans, and possibly nuclear imaging. Your medical history, current symptoms, and test results will be compared with the blood particle findings to see if they can predict disease severity and progression.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Brazil